Common symptoms include anemia, fatigue, weakness, lightheadedness, pale skin, and neurological issues such as tingling or numbness in the hands and feet, muscle weakness, memory problems, poor appetite, and mood changes
With 90 degrees insertion, needles 4-5 mm enter the subcutaneous tissue with minimal risk of IM injection in virtually all adults
No human clinical trials exist
All participants were non-smokers
Mercury is the number one toxin, even more significant than lead
the question is whether systems will track outcomes rigorously once access widens